OPKO Health

OPKO Health Incorporation
Public
Traded as NYSE: OPK
TASE: OPK
Industry Medical Appliances & Equipment
Headquarters Miami, Florida.
Products Medical Products
Website www.opko.com

OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals.[1] The company develops treatments for secondary hyperparathyroidism, and has recently finished the patient recruitment for a Phase III trial against insufficiency in Vitamin D.[2] The company is a publicly traded company on NYSE under the symbol "OPK". It acquired Laboratorio Arama de Uruguay in 2014 and is seeking to expand its presence in Uruguay and Argentina.[1]

History

OPKO Health Incorporation focuses on production of cardiovascular products, vaccines, hormones, antibiotics, gastrointestinal products, and eye care. The company operates in the U.S., Chile, Israel, Mexico, Uruguay, and Spain.[3]

Production

The productions of OPKO Health Incorporation include mainly two segments: Pharmaceuticals and Diagnostics.[4] The company is recently expanding collaboration with Bristol-Myers Squibb Co. on diagnostic test technology, which involves blood tests identifying biomarkers of diseases.[5]

Corporate affairs

In December 2013 OPKO Health completed the sale of its stake in Sorrento Therapeutics.[6] The company entered into a stock purchase agreement with Sorrento in 2009.

Stocks

The ticker symbol for OPKO Health Incorporation is "OPK", under which the company went public on NYSE.[7]

References

External links

This article is issued from Wikipedia - version of the 10/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.